HLS Therapeutics Inc (DE:74D)

HLS Therapeutics Inc (74D) Income Statement


HLS Therapeutics Inc Income Statement

Last quarter (Q4 2023), HLS Therapeutics Inc's total revenue was $15.86M, an increase of 1.20% from the same quarter last year. In Q4, HLS Therapeutics Inc's net income was $-5.40M. See HLS Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 63.07M$ 63.07M$ 61.47M$ 60.01M$ 56.11M$ 54.16M
Cost of Revenue
$ 7.62M$ 7.62M$ 4.98M$ 3.97M$ 3.63M$ 1.93M
Gross Profit
$ 55.45M$ 55.45M$ 56.49M$ 56.04M$ 52.48M$ 52.23M
Operating Expense
$ 69.58M$ 69.58M$ 70.78M$ 62.32M$ 64.57M$ 56.86M
Operating Income
$ -14.13M$ -14.13M$ -14.29M$ -6.28M$ -12.09M$ -4.63M
Net Non Operating Interest Income Expense
$ -8.40M$ -8.40M$ -7.26M$ 6.91M$ -5.99M$ -7.11M
Other Income Expense
$ 5.32M$ 5.32M$ -2.33M$ 1.39M$ 1.77M$ -8.72M
Pretax Income
$ -27.80M$ -27.80M$ -23.72M$ -11.81M$ -16.30M$ -20.46M
Tax Provision
$ -272.00K$ -272.00K$ -124.00K$ 1.31M$ -968.00K$ -911.00K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -27.53M$ -27.53M$ -23.60M$ -13.12M$ -15.33M$ -19.55M
Basic EPS
----$ -0.48$ -0.67
Diluted EPS
----$ -0.48$ -0.67
Basic Average Shares
----$ 31.71M$ 29.36M
Diluted Average Shares
----$ 31.71M$ 29.36M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 77.21M$ 77.21M$ 75.76M$ -66.29M$ 68.20M$ 58.79M
Net Income From Continuing And Discontinued Operation
$ -27.53M$ -27.53M$ -23.60M$ -13.12M$ -15.33M$ -19.55M
Normalized Income
$ -20.49M$ -24.18M$ -19.45M$ -8.51M$ -16.52M$ -11.22M
Interest Expense
----$ 6.31M$ 7.70M
$ -19.05M$ -19.05M$ -16.41M$ -4.85M$ -9.99M$ -12.76M
$ 12.88M$ 12.88M$ 18.00M$ 25.41M$ 23.19M$ 19.75M
Currency in USD

HLS Therapeutics Inc Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis